May 12, 2021 / 03:00PM GMT
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity Research
Good day, everybody. Thank you for joining us for the Bank of America Annual Healthcare Conference. My name is Jason Gerberry. I am one of the analysts at BofA covering biopharma. So I cover specialty pharma and biotech, and I'm pleased to be introducing our next company presenter, Bausch Health, and CEO, Joe Papa.
So Joe, Thanks for joining us. Hot off the heels of your 1Q update.
Joseph C. Papa - Bausch Health Companies Inc. - CEO & Chairman
Thank you, Jason. Thank you, everybody. Pleasure to be here.
Questions and Answers:
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity ResearchSo not surprising, I think some of the questions that we've been fielding over the last week or so kind of mainly around the proposed intent to separate the businesses, unlock shareholder value. You had the 1Q update, you revised some of the capitalization targets. The markets reacted, how the markets